Celogics logo

Celogics

Quality Cells, Quality Research. Providing iPSC differentiation services for pharmaceutical research

3 employees · est. 2021 · Seattle, United States

VS
Genís logo

Genís

An innovative Icelandic biotechnology company

28 employees · est. 2005 · Iceland

Genís is the older company (2021 vs 2005); Genís is the larger of the two.

Side-by-Side Comparison

Celogics Genís
Founded
2021 2005 older
Headquarters
Seattle, United States Iceland
Employees
3 28 larger
Industry
Biotechnology, Manufacturing Biotechnology, Health Care, Medical Devices
Funding Stage
Not tracked yet Series Unknown
Total Funding
Not tracked yet $100.05M
Funding Rounds
Not tracked yet 6
Services
Custom Cardiomyocytes Development, High-Quality Human iPSC-derived Cell Products, Drug Development Acceleration, Disease Modeling Research Not tracked yet
Target Customers
Pharmaceutical Companies, Biotech Researchers, Medical Research Institutions, Disease Modelers Not tracked yet
Taxonomy
IPSC Differentiation, Pharmaceutical Research, Human Cell Culture, Research-use-only Cell Products, Drug Discovery, Drug Safety Screening, Disease Modeling, IPSC-derived Cells, Life Sciences, Functional Cell Models, Celo.Cells Brand, Biotechnology Joint Venture, Cell Manufacturing, Validated Data Provision, Cell Model Innovation Pharmaceuticals, Bioactive Substances, Crustacean Exoskeletons, Chitin, Chitosan, Oligosaccharides, Inflammatory Conditions, Degenerative Conditions, Icelandic Company, Innovation, Life-changing Products
Website
celogics.com genis.is
Celogics logo

About Celogics

Celogics, founded in 2021, is carving a niche in the biotechnology and manufacturing sectors by pioneering advanced iPSC differentiation services tailored for pharmaceutical research. With the mission of enhancing the quality of human cell culture, Celogics aims to revolutionize research by producin...

Genís logo

About Genís

Genís is an innovative Icelandic biotechnology company that was founded in 2005 and is headquartered in Siglufjörður, Iceland. The company's mission is to discover, develop, and commercialize novel and life-changing pharmaceutical products, supplements, and medical devices derived from crustacean ex...

We will tell you when either one moves

BounceWatch watches Celogics and Genís for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Celogics and Genís — by email.

Frequently Asked Questions

Celogics — Quality Cells, Quality Research. Providing iPSC differentiation services for pharmaceutical research. Genís — An innovative Icelandic biotechnology company. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Celogics has raised undisclosed funding while Genís has raised $100.05M.
Celogics and Genís operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Celogics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Celogics on 4 Mar 2026, and Genís on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes